Ruigang Diao

4PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 10, 2026
Cost-effectiveness analysis of finotonlimab in the treatment of advanced recurrent metastatic head and neck squamous cell carcinoma in China.

|Feb 24, 2026
Cost-effectiveness of sugemalimab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced oesophageal squamous cell carcinoma in China.

Chunyan Yan, Zhengxiong Li, Jiayan Li

|Mar 03, 2025
Cost-effectiveness analysis of penpulimab combined with paclitaxel and carboplatin as a first-line treatment for metastatic squamous non-small cell lung cancer in China.

Liangxiao Wang, Na Lv, Yuan Gao

|Mar 18, 2023
Genistein attenuates renal ischemia-reperfusion injury via ADORA2A pathway.

H Y He, H Z Shan, S Q Li

Pageof 1

Frequent Collaborators

1 joint publications

Liangxiao Wang